Cargando…
Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients
The aim of this study was to explore the value of autoantibody to GNAS in the early detection of hepatocellular carcinoma (HCC). In a large-scale sample set of 912 participants (228 cases in each of HCC, liver cirrhosis (LC), chronic hepatitis B (CHB), and normal controls (NCs) groups), autoantibody...
Autores principales: | Wang, Xiao, Wang, Keyan, Qiu, Cuipeng, Wang, Bofei, Zhang, Xiaojun, Ma, Yangcheng, Dai, Liping, Zhang, Jian-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773227/ https://www.ncbi.nlm.nih.gov/pubmed/35052777 http://dx.doi.org/10.3390/biomedicines10010097 |
Ejemplares similares
-
Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans
por: Qiu, Cuipeng, et al.
Publicado: (2023) -
Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma
por: Ma, Yangcheng, et al.
Publicado: (2022) -
Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2023)